Nascent Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	Current	2023	2022	2021	2020	2019	2018 - 2012
Market Capitalization	12	28	7	6	4	9	Upgrade
Market Cap Growth	20.99%	320.33%	8.60%	36.92%	-51.34%	71.13%	Upgrade
Enterprise Value	11	28	7	6	5	9	Upgrade
PE Ratio	-	-13.43	-2.38	-41.58	-3.41	-2.25	Upgrade
PS Ratio	-	-	-	6.14	5.98	-	Upgrade
PB Ratio	391.25	-109.22	-5.15	-9.15	-9.49	-3.21	Upgrade
P/FCF Ratio	-23.68	-23.64	-3.73	14.85	-4.55	-16.63	Upgrade
P/OCF Ratio	-23.68	-23.64	-3.73	14.85	-4.55	-16.63	Upgrade
EV/Sales Ratio	-	-	-	6.05	6.19	-	Upgrade
EV/EBITDA Ratio	-12.61	-12.41	-3.19	-9.94	-3.27	-2.71	Upgrade
EV/EBIT Ratio	-9.91	-10.61	-1.97	-	-	-	Upgrade
EV/FCF Ratio	-23.28	-23.32	-3.85	14.62	-4.71	-16.87	Upgrade
Debt / Equity Ratio	4.12	0	-0.30	0	-0.34	-0.05	Upgrade
Debt / EBITDA Ratio	-0.06	-	-0.18	-	-0.11	-0.04	Upgrade
Debt / FCF Ratio	-0.10	-	-0.22	-	-0.16	-0.25	Upgrade
Quick Ratio	1.02	0.46	0.11	0.12	0.61	0.00	Upgrade
Current Ratio	1.05	0.68	0.16	0.14	0.61	0.00	Upgrade
Asset Turnover	0	0	0	9.49	1.00	0	Upgrade
Interest Coverage	-14.64	5.79	-1.25	-1.36	-4.16	-39.79	Upgrade
Return on Equity (ROE)	-6892.89%	813.36%	216.10%	22.00%	278.26%	142.25%	Upgrade
Return on Assets (ROA)	-326.40%	-378.12%	-1098.41%	-140.12%	-174.97%	-127121.78%	Upgrade
Return on Capital (ROIC)	-1450.55%	868.76%	237.80%	68.07%	450.61%	125.96%	Upgrade
Earnings Yield	-17.62%	-7.45%	-42.00%	-2.41%	-29.31%	-44.38%	Upgrade
FCF Yield	-10.28%	-4.23%	-26.80%	6.73%	-22.00%	-6.01%	Upgrade
Buyback Yield / Dilution	-39.95%	-31.35%	-10.05%	-48.93%	-110.34%	-14.30%	Upgrade
Total Shareholder Return	-39.95%	-31.35%	-10.05%	-48.93%	-110.34%	-14.30%	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.